We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.5M
AUM Growth
-$140M
Cap. Flow
-$147M
Cap. Flow %
-161.07%
Top 10 Hldgs %
32.18%
Holding
147
New
3
Increased
5
Reduced
92
Closed
38

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$327K
2
COL
Rockwell Collins
COL
+$213K
3
CBRL icon
Cracker Barrel
CBRL
+$19.9K
4
SRCL
Stericycle Inc
SRCL
+$18.3K
5
FRC
First Republic Bank
FRC
+$11.6K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$6.51M
2
CNI icon
Canadian National Railway
CNI
+$5.43M
3
NVS icon
Novartis
NVS
+$5.24M
4
MA icon
Mastercard
MA
+$5.23M
5
JNJ icon
Johnson & Johnson
JNJ
+$5.15M

Sector Composition

Rank Sector Weight
1 Technology 24.99%
2 Healthcare 21.06%
3 Industrials 19.34%
4 Energy 10.11%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$119B
$3.7M 4.04%
38,371
-73,935
-66% -$6.51M
PG icon
2
Procter & Gamble
PG
$334B
$3.23M 3.53%
35,450
-48,066
-58% -$4.23M
JNJ icon
3
Johnson & Johnson
JNJ
$646B
$3.19M 3.49%
30,555
-48,905
-62% -$5.15M
NVS icon
4
Novartis
NVS
$292B
$3.07M 3.36%
37,012
-63,216
-63% -$5.24M
CNI icon
5
Canadian National Railway
CNI
$76.2B
$2.93M 3.21%
42,560
-79,380
-65% -$5.43M
MMM icon
6
3M
MMM
$89.9B
$2.85M 3.12%
20,772
-35,049
-63% -$4.5M
XOM icon
7
ExxonMobil
XOM
$644B
$2.76M 3.01%
29,834
-24,231
-45% -$2.26M
AAPL icon
8
Apple
AAPL
$4.67T
$2.6M 2.84%
94,192
-179,352
-66% -$4.88M
EMR icon
9
Emerson Electric
EMR
$86.6B
$2.55M 2.79%
41,310
-69,245
-63% -$4.34M
ATR icon
10
AptarGroup
ATR
$8.46B
$2.42M 2.64%
36,180
-53,110
-59% -$3.37M
MA icon
11
Mastercard
MA
$521B
$2.34M 2.56%
27,130
-64,100
-70% -$5.23M
ADP icon
12
Automatic Data Processing
ADP
$114B
$2.32M 2.53%
27,785
-60,863
-69% -$4.93M
INTC icon
13
Intel
INTC
$473B
$1.99M 2.17%
54,810
-113,576
-67% -$3.95M
FISV
14
Fiserv Inc
FISV
$28.3B
$1.97M 2.16%
55,570
-107,300
-66% -$3.67M
EMC
15
DELISTED
EMC CORPORATION
EMC
$1.95M 2.13%
65,433
-138,975
-68% -$4.04M
ORCL icon
16
Oracle
ORCL
$435B
$1.82M 1.99%
40,389
-96,165
-70% -$3.91M
QCOM icon
17
Qualcomm
QCOM
$175B
$1.75M 1.92%
23,585
-40,710
-63% -$2.98M
NXPI icon
18
NXP Semiconductors
NXPI
$56.4B
$1.68M 1.84%
22,020
-36,190
-62% -$2.57M
PEP icon
19
PepsiCo
PEP
$193B
$1.61M 1.76%
17,069
-37,540
-69% -$3.6M
RTX icon
20
RTX Corp
RTX
$285B
$1.61M 1.76%
22,240
-37,198
-63% -$2.54M
CVX icon
21
Chevron
CVX
$396B
$1.61M 1.76%
14,321
-27,180
-65% -$3.09M
JCI icon
22
Johnson Controls International
JCI
$84.6B
$1.54M 1.68%
30,431
-49,249
-62% -$2.41M
ABT icon
23
Abbott
ABT
$195B
$1.54M 1.68%
34,115
-48,195
-59% -$2.1M
PBA icon
24
Pembina Pipeline
PBA
$27.9B
$1.38M 1.5%
37,800
-61,790
-62% -$2.34M
GIS icon
25
General Mills
GIS
$22.2B
$1.31M 1.44%
24,660
-3,275
-12% -$169K
1
2 3 4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q4 2014 Portfolio in Review

As of Q4 2014, Michael B. Elefante held 147 positions worth $91.5M, down 61% from $232M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael B. Elefante withdrew a net $147M in Q4 2014, closing 38 positions and reducing 92 holdings. Its most notable exit was Labcorp, an estimated $1.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Michael B. Elefante opened a new position in CDK Global, Inc. worth $375K.

  • Michael B. Elefante's largest Q4 2014 buy was CDK Global, Inc.: 9,235 shares worth $375K.
  • Michael B. Elefante added most to Stericycle Inc in Q4 2014, an estimated $18.3K increase.
  • Michael B. Elefante's biggest Q4 2014 reduction was CVS Health, cutting an estimated $6.51M.
  • Michael B. Elefante fully exited Labcorp in Q4 2014, selling an estimated $1.76M.
  • Michael B. Elefante's ten largest holdings make up 32% of its $91.5M portfolio in Q4 2014.
  • Michael B. Elefante opened 3 new positions and closed 38 in Q4 2014.
  • Michael B. Elefante's portfolio value fell 61% quarter-over-quarter to $91.5M.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.